CLINICAL PATHWAYS FOR ACUTE CARE IN TASMANIAN EMERGENCY DEPARTMENTS
With Associate Professor Viet Tran, Deputy Director of Emergency Medicine at Royal Hobart Hospital & Founding Director, Tasmanian Emergency Medicine Research Institute & Emergency Medicine Discipline Lead, University of Tasmania, Tasmania, Australia
RESEARCHER PROFILE
Filmed in Hobart, Australia | July 2025
Viet Tran is Associate Professor of Emergency Medicine at the University of Tasmania, Founding Director of the Tasmanian Emergency Medicine Research Institute, Deputy Director of Emergency Medicine at Royal Hobart Hospital, Chair of the Tasmanian Emergency Departments Network and Inaugural Co-Chair of the Tasmanian Health Senate.
A/Prof Tran also works at the coalface of healthcare as an Emergency Physician and continually advocates for excellence in patient care through education, research, quality and safety and health reform.
He has built Emergency Medicine Research in Tasmania from the ground up, which has culminated in the success of a AUD$3 million Australian Government Medical Research Futures Fund grant looking into the Implementation of Clinical Pathways for Acute Care in Tasmania project. Dr Tran is also the Emergency Medicine Discipline lead within the Tasmanian School of Medicine and has key roles to play within Emergency Medicine training. He feels privileged to be able to teach and mentor across the whole spectrum of becoming a doctor, from watching students grow into junior doctors, senior registrar and as fellow medical specialists.
Source: University of Tasmania website
-
Respiratory health and the microbiome in the lung environment
Dr Taylor leads the Respiratory Health Group within the Microbiome and Host Health Program. His research employs tailored techniques that allow the lung environment to be characterised to a high level of accuracy, including detailed measurements of airway microbiology (microbiome), mucus composition, and inflammation. This information is used to identify predictive markers of chronic lung disease severity as well as determine effective forms of therapy.
-
Superslayer taking on antibiotic-resistant bacteria
Dr Katharina Richter is a visionary leader in MedTech, acclaimed for innovation and gender diversity. With over 40 awards to her name, including MIT Innovator Under 35 Asia-Pacific, and Prime Minister’s Prize for New Innovator finalist, she has shattered barriers as an entrepreneur, scientist, and ‘superbug slayer.’ Katharina’s groundbreaking work in combating antibiotic-resistant bacteria has resulted in 6 innovative treatments, 3 of which are patented, offering hope against deadly infections.
-
Systems genetics to determine risk of developing diabetes complications
Professor Morahan invented the term “Systems Genetics” for the science field that examines how genetic variants can affect whole networks of genes and whole systems; there are now several laboratories and institutes of systems genetics around the world. He also developed the next-generation genetic resource, The Gene Mine, the most powerful of its type in the world, used globally in rapid mapping and identification of genes. Collaborators nationally and internationally have tested The Gene Mine for traits and diseases in which they specialise.
